The Effects of Olfactory Stimulation on Diagnosis and Prognosis of DOC Patients

Sponsor
Jing Wang (Other)
Overall Status
Completed
CT.gov ID
NCT03732092
Collaborator
(none)
20
1
21
1

Study Details

Study Description

Brief Summary

Analyze the behavioral response of patients with disorders of consciousness through olfactory stimulation, compare the response of olfactory stimulation in patients with different consciousness, and analyze the impact of olfactory stimulation on diagnosis; After the first, third, and sixth months of initial enrollment, the recovery of prognosis was tracked by the Coma Recovery Scale-Revision (CRS-R).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Coma Recovery Scale-Revised

Detailed Description

Previous studies suggested that olfactory stimulus have some effect on some patients with disorders of consciousness. Then, the aim of the present study is to know the prognostic value of olfactory stimulation and the diagnosis for DOC patients. DOC patients were recruited (standard diagnosis procedure is 5 times CRS-R testing within 10 days). The different stimuli were as follows: 1) 1-octene-3-ol, odor. 2) pyridine, odor. 3) water. We presented these stimuli randomly, and we recorded the patient's CRS-R scale behavioral response and response to olfactory stimulation. Analyze the behavioral response of patients with disorders of consciousness through olfactory stimulation, compare the response of olfactory stimulation in patients with different consciousness, and analyze the impact of olfactory stimulation on diagnosis; After the first, third, and sixth months of initial enrollment, the recovery of prognosis was tracked by the Coma Recovery Scale-Revision (CRS-R).

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Effects of Olfactory Stimulation on Diagnosis and Prognosis of Patients With Disorders of Consciousness
Actual Study Start Date :
Mar 15, 2018
Actual Primary Completion Date :
Nov 15, 2018
Actual Study Completion Date :
Dec 15, 2019

Arms and Interventions

Arm Intervention/Treatment
patients with disorders of consciousness

Patients with disorders of consciousness from several brain injury, assessed by Coma Recovery Scale-Revised (CRS-R), have been clinically classified into coma, unresponsive wakefulness syndrome and minimally conscious state.

Diagnostic Test: Coma Recovery Scale-Revised
Patients with disorders of consciousness were assessed by Coma Recovery Scale-Revised (CRS-R). In addition, we selected three stimuli: 1) 1-octene-3-ol, 2) pyridine, 3) water. We presented these three stimuli in front of the patients nose for 3 seconds.

Outcome Measures

Primary Outcome Measures

  1. Coma Recovery Scale-Revised (CRS-R) [six months later]

    The CRS-R consists of 23 items grouped in six subscales addressing auditory, visual, motor, oromotor, communication and arousal functions. The higher items represent conscious related behaviour while the lower items for each sub-scale represent reflexive activity. Basis for scoring was the presence or absence of the specific behaviour in response to standard stimuli. Patients were followed up for 1, 3, and 6 months to track the prognosis of patients by CRS-R.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-65 years old;

  • non-acute phase;

  • after coma;

  • no nerve stimulation drugs within 48 hours before the implementation of the study;

  • no neuromuscular blockers within 24 hours before implementation

Exclusion Criteria:
  • history of forehead injury;

  • nasal fractures;

  • tracheotomy;

  • developmental mental or neurological diseases leading to recorded dysfunction;

  • severe fractures of the extremities.

Contacts and Locations

Locations

Site City State Country Postal Code
1 International Vegetative State and Consciousness Science Institute, Hangzhou Normal University Hangzhou Zhejiang China 3100036

Sponsors and Collaborators

  • Jing Wang

Investigators

  • Study Chair: Patients with disorders of consciousness were assessed by Coma Di, Pro, International Vegetative State and Consciousness Science Institute, Hangzhou Normal University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jing Wang, Principal Investigator, Hangzhou Normal University
ClinicalTrials.gov Identifier:
NCT03732092
Other Study ID Numbers:
  • 2018A04355
First Posted:
Nov 6, 2018
Last Update Posted:
Dec 29, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jing Wang, Principal Investigator, Hangzhou Normal University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2020